In melanoma, inhibiting the expression of the long noncoding RNA AGAP2-AS1 has the functional effect of reducing carcinogenesis and ferroptosis resistance via the SLC7A11-IGF2BP2 pathway. This evidence concerns the gene SLC7A11 and melanoma.